Projects

How do we communicate risk to providers who are prescribing to pregnant and lactating women?

Assessing changes to prescription drug labeling for pregnant and lactating women

Challenge

The U.S. Food and Drug Administration (FDA) is revising the way that risk information relating to prescribing to pregnant and lactating women is presented in prescription drug labeling. Risks and benefits must be communicated to prescribing health care professionals in a clear and efficient way.

Solution

Westat is conducting focus groups with health care providers to gather feedback on proposed changes to prescription drug labeling for pregnant and lactating women. 

In response to COVID-19, virtual focus groups are being conducted, allowing us to gather feedback across the country during a challenging time for health care providers.

Results

FDA will use the results of the focus groups to improve risk messaging for health care providers making decisions about prescribing to pregnant and lactating women.

The project will serve as a model for health care provider feedback in developing risk messaging in prescription labeling.

Insights

Deep Dive with Our Experts

view all insights
  • Perspective

    Highlights of Westat at AAPOR 2024

    May 2024

    We’ve returned from the 79th Annual American Association for Public Opinion Research (AAPOR) Conference, held May 15-17 in Atlanta, where we caught up with colleagues…

  • Expert Interview

    PMGE: Blueprint for Culturally Responsive Evaluations

    May 2024

    Long known for its cutting-edge studies, the Office of Planning, Research, and Evaluation (OPRE), a department of the Administration for Children and Families (ACF), has…

  • Perspective

    Westat @ AAPOR 2024

    May 2024

    Westat experts are excited to head to Atlanta May 15-17, 2024, for the American Association for Public Opinion Research (AAPOR) 79th Annual Conference. We’re proud…

Projects

Keep Reading

view all projects

How can we help?

We welcome messages from job seekers, collaborators, and potential clients and partners.

Get in Contact

Want to work with us?

You’ll be in great company.

Explore Careers
Back to Top